Skip to content

Oruka Therapeutics, Inc. ORKA Nontaxable or Nondeductible items

Nontaxable or Nondeductible items at other companies

First BanCorp logo
First BanCorpFBP
-$934K+18.9%
Skyline Champion logo
Skyline ChampionSKY
$345K
Ondas, Inc.
 logo
Ondas, Inc. ONDS
-0.1%0.0pp
ESN
Essent GroupESNT
$787K-11.1%
KEE
Keel Infrastructure Corp. Common StockKEEL
-2.3%
BancFirst Corporation logo
BancFirst CorporationBANF
-$728.5K

Other financials

Income statement

See full
Revenue-
Operating income-$36.4M-45.2%
Net income-$31.8M-51.5%
EPS (diluted)-$0.46+93.4%

Balance sheet

See full
Cash & equivalents$49.5M-40.7%
Total debt$1.8M+90.8%
Total equity$486.7M+33.4%
Total assets$504.5M+33.8%

Cash flow

See full
Operating cash flow-$23.6M-13.0%
CapEx$73.0K+462%
Free cash flow-$23.7M-13.3%

Valuation

See full
Market cap$4.36B+533%
Enterprise value$4.32B+690%

Returns & leverage

See full
Return on equity-27.3%-11.1pp
Debt / equity0.0×
Current ratio23.8×-6.3×

Where this comes from

Reported directly by Oruka Therapeutics, Inc. in its filing.

Tagged under the XBRL concept us-gaap:IncomeTaxReconciliationNondeductibleExpense.

The official record: Oruka Therapeutics, Inc.’s 10-K, filed March 12, 2026, on SEC EDGAR. View the filing →

Ask your AI about Oruka Therapeutics, Inc.'s nontaxable or nondeductible items.

Connect your AI assistant and compare it to peers, right in your chat.

Connect your AI
Harbor at dusk
Claude

Questions, answered.

What is Oruka Therapeutics, Inc.'s nontaxable or nondeductible items?
Oruka Therapeutics, Inc. (ORKA) reported nontaxable or nondeductible items of $13.5K in Q4 2025.
How has Oruka Therapeutics, Inc.'s nontaxable or nondeductible items changed year-over-year?
Oruka Therapeutics, Inc.'s nontaxable or nondeductible items decreased by 82.2% year-over-year, from $76K to $13.5K.
What does nontaxable or nondeductible items mean?
The portion of expenses incurred by the company that are not tax-deductible under current tax regulations. These expenses increase the company's effective tax rate because they cannot be used to offset taxable income. Monitoring this helps investors understand the gap between accounting profit and taxable income.